Retatrutide

A Study of LY3437943 in Participants Who Have Obesity or Are Overweight

A Study of LY3437943 in Healthy Participants and Participants With Impaired Renal Function

A Study of LY3437943 in Postmenopausal Female Participants Who Are Overweight or Obese

To Investigate the Effect of Retatrutide (LY3437943) on Metoprolol Pharmacokinetics in Healthy Participants

A Study of Retatrutide (LY3437943) in the Maintenance of Weight Reduction in Individuals With Obesity

Metabolic inflammation at the adipose-brain axis.

Mateus-Gomes S, Al-Sayyar A, Lobey B et al.

GIPR:GCGR co-agonism restores normal weight in obese rodents.

Perez-Tilve D, Zhang F, Zhang Y et al.

Multi-omic profiling reveals Retatrutide alleviates adipose tissue fibrosis via metabolic reprogramming and tissue repair.

Li Q, Cheng W, Zhang J et al.

Obesity pharmacotherapy reimagined: The era of multi-receptor agonists and next-generation metabolic modulators, perspectives and controversies.

Lempesis IG, Dalamaga M

Childhood obesity and cardiac risk in youth: Emerging challenges toward 2050.

Mishra NK